Company / CapEx per Share
Larimar Therapeutics, Inc. CapEx per Share History
FY2014-FY2019 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2019
5-year range
$0.00 / $0.02
FY2015-FY2019
Trend
-93.9%
vs FY2018
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.02 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2019 with a 5-year CAGR of -11.7%.
Declined from $0.02 to $0.00 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -11.5%
- 5-Year CAGR
- -11.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2019, capex per share decreased 93.9% year-over-year.
- Peak capex per share was recorded in FY2018.
- Lowest capex per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.64 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2019 | $0.00 | -93.9% |
| FY2018 | $0.02 | +10.3% |
| FY2017 | $0.02 | +922.5% |
| FY2016 | $0.00 | +186.5% |
| FY2015 | $0.00 | -72.9% |
| FY2014 | $0.00 | - |
As of FY2019 · SEC 10-K · Updated Jun 24, 2026